Canadian Hemophilia Society – Dream of a Cure Research Program
Funder’s Website
The funder’s website can be found HERE.
Funding Value and Duration
Individual grants valued at $75,000 per year and per project will be awarded to researchers for a maximum of $150,000 which can be expended over 2 or 3 years. If a two year award is provided, the second year of funding is dependent on evidence of progress as described in the required progress report. Grant funding will begin on April 1 of each year.
Yearly grants will normally be disbursed in two payments in each year.
Overview
Supporting research towards improving the health and the quality of life of all people with inherited bleeding disorders and finding a cure have been goals of the Canadian Hemophilia Society (CHS) since it was founded in 1953. Since 1990 through funds provided by the Hemophilia Research Million Dollar Club and the CHS, the CHS provides basic scientific research grants and studentships aimed at developing treatments for hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders and ultimately, at finding a cure.
Eligibility Criteria
Applicants must be Canadian citizens or permanent residents and affiliated with a Canadian university or not-for-profit health-related organization.
Internal Contacts
Potential applicants are encouraged to discuss this funding opportunity with their Faculty Research Facilitator.
Deadlines
| Faculty Deadline | Consult your Faculty Research Facilitator. |
| OVPRII Deadline (Approval Form and Application) | November 22, 2024 |
| Submission to Sponsor | November 29, 2024 |
Submitting Your Application
- Step 1) Submit an internal Carleton Approval Form
Submit an internal Approval Form through our central awards management database CUResearch:
https://ovpri.research.carleton.ca/Romeo.Researcher/Administrator/Default.aspx
For a user’s guide on submitting an Approval Form, click HERE. - Step 2) Submit an external application to the granting agency
Submit an external application to the corresponding grant or award agency. To navigate to the funder’s website, click HERE